GENZYME CORP Research and Development Expense (Excluding Acquired in Process Cost)
GENZYME CORP reported Research and Development Expense (Excluding Acquired in Process Cost) of $220.93 million for the 3-month period ending 2010-03-31, per its 10-Q/A filed 2010-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost · last filed 2010-06-14
- GENZYME CORP research and development expense (excluding acquired in process cost) for the quarter ending 2010-03-31 was $220.93M, a 6.77% increase year-over-year.
- GENZYME CORP research and development expense (excluding acquired in process cost) for the quarter ending 2009-12-31 was $228.53M, a 36.24% decline year-over-year.
- GENZYME CORP research and development expense (excluding acquired in process cost) for the quarter ending 2009-09-30 was $219.28M, a 28.16% decline year-over-year.
- GENZYME CORP research and development expense (excluding acquired in process cost) for the quarter ending 2009-06-30 was $210.52M, a 44.87% decline year-over-year.
| Period end | Research and Development Expense (Excluding Acquired in Process Cost) 3 month | Research and Development Expense (Excluding Acquired in Process Cost) 6 month | Research and Development Expense (Excluding Acquired in Process Cost) 9 month | Research and Development Expense (Excluding Acquired in Process Cost) 12 month |
|---|---|---|---|---|
| 2010-03-31 | $220.93M 10-Q/A · filed 2010-05-11 | $449.46M derived: sum of 2 quarters · filed 2010-06-14 | $668.74M derived: sum of 3 quarters · filed 2010-06-14 | $879.26M derived: sum of 4 quarters · filed 2010-06-14 |
| 2009-12-31 | $228.53M derived: 8-K 12 month − 10-Q 9 month · filed 2010-06-14 | $447.81M derived: sum of 2 quarters · filed 2010-06-14 | $658.33M derived: sum of 3 quarters · filed 2010-06-14 | $865.26M 8-K · filed 2010-06-14 |
| 2009-09-30 | $219.28M 10-Q · filed 2009-11-02 | $429.80M derived: sum of 2 quarters · filed 2009-11-02 | $636.72M 10-Q · filed 2009-11-02 | $995.15M derived: sum of 4 quarters · filed 2010-06-14 |
| 2009-06-30 | $210.52M 10-Q/A · filed 2009-09-04 | $417.45M 10-Q/A · filed 2009-09-04 | $775.88M derived: sum of 3 quarters · filed 2010-06-14 | $1.08B derived: sum of 4 quarters · filed 2010-06-14 |
| 2009-03-31 | $206.93M 10-Q/A · filed 2010-05-11 | $565.36M derived: sum of 2 quarters · filed 2010-06-14 | $870.60M derived: sum of 3 quarters · filed 2010-06-14 | $1.25B derived: sum of 4 quarters · filed 2010-06-14 |
| 2008-12-31 | $358.43M derived: 8-K 12 month − 10-Q 9 month · filed 2010-06-14 | $663.67M derived: sum of 2 quarters · filed 2010-06-14 | $1.05B derived: sum of 3 quarters · filed 2010-06-14 | $1.31B 8-K · filed 2010-06-14 |
| 2008-09-30 | $305.24M 10-Q · filed 2009-11-02 | $687.10M derived: sum of 2 quarters · filed 2009-11-02 | $949.90M 10-Q · filed 2009-11-02 | |
| 2008-06-30 | $381.86M 10-Q/A · filed 2009-09-04 | $644.66M 10-Q/A · filed 2009-09-04 | ||
| 2007-12-31 | $737.68M 8-K · filed 2010-06-14 |